B3GALNT2-LYST Fusion FISH Probe
The B3GALNT2-LYST Fusion FISH Probe is used to confirm a fusion of the B3GALNT2 and LYST genes. The fusion of the B3GALNT2 and LYST genes has been associated with Bladder Urothelial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| B3GALNT2-LYST-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| B3GALNT2-LYST-20-RERE | 20 (40 μL) | 200 μL |
|
|
| B3GALNT2-LYST-20-REOR | 20 (40 μL) | 200 μL |
|
|
| B3GALNT2-LYST-20-REGO | 20 (40 μL) | 200 μL |
|
|
| B3GALNT2-LYST-20-REGR | 20 (40 μL) | 200 μL |
|
|
| B3GALNT2-LYST-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| B3GALNT2-LYST-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| B3GALNT2-LYST-20-OROR | 20 (40 μL) | 200 μL |
|
|
| B3GALNT2-LYST-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| B3GALNT2-LYST-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| B3GALNT2-LYST-20-GORE | 20 (40 μL) | 200 μL |
|
|
| B3GALNT2-LYST-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| B3GALNT2-LYST-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| B3GALNT2-LYST-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| B3GALNT2-LYST-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| B3GALNT2-LYST-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| B3GALNT2-LYST-20-GROR | 20 (40 μL) | 200 μL |
|
|
| B3GALNT2-LYST-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| B3GALNT2-LYST-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| B3GALNT2-LYST-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| B3GALNT2-LYST-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| B3GALNT2-LYST-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| B3GALNT2-LYST-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| B3GALNT2-LYST-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| B3GALNT2-LYST-20-AQAQ | 20 (40 μL) | 200 μL |
|
LYST Gene Summary
This gene encodes a protein that regulates intracellular protein trafficking in endosomes, and may be involved in pigmentation. Mutations in this gene are associated with Chediak-Higashi syndrome, a lysosomal storage disorder. Alternative splicing results in multiple transcript variants, though the full-length nature of some of these variants has not been determined. [provided by RefSeq, Apr 2013]
Gene Name: Lysosomal Trafficking Regulator
Chromosome: CHR1: 235824344 -236030220
Locus: 1q42.3
B3GALNT2 Gene Summary
This gene encodes a member of the glycosyltransferase 31 family. The encoded protein synthesizes GalNAc:beta-1,3GlcNAc, a novel carbohydrate structure, on N- and O-glycans. Alternatively spliced transcript variants that encode different isoforms have been described. [provided by RefSeq, Mar 2013]
Gene Name: Beta-1,3-N-acetylgalactosaminyltransferase 2
Chromosome: CHR1: 235610532 -235667781
Locus: 1q42.3
Gene Diseases
The B3GALNT2 LYST Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Bladder Urothelial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|